eMedevents
  • 132741+ Medical Conferences
  • 251 Specialties
  • 34861 Organizers
  • 148791 Speakers
  • 155 Countries
  • 4471 Cities
44247+
CME Conference Registrations Sold
Home  >  Speakers  >  Neil Carragher
Neil Carragher

Neil Carragher

    BSc(Hons), PhD
Director, Professor | Edinburgh, Scotland    United Kingdom
Clinical Pharmacology
Clinical Pharmacology, Drug-Discovery; Pharmaco-proteomics,...More
Spoken at 4 events

Biography :

Professor Neil Carragher graduated from the University of Aberdeen, Scotland UK in 1992 with a B.Sc Honours degree in the subject of “Cell and Immunobiology”. He then took up a position within industry at the Yamanouchi Research Institute, Oxford, England UK where he also gained his PhD. He then held consecutive postdoctoral positions within the Department of Pathology, University of Washington, Seattle, USA and at the Beatson Institute for Cancer Research, Glasgow, Scotland UK

In 2010 he once again made the career switch from industry to academia and took up the post of Principal Investigator of Drug Discovery at the University of Edinburgh where he leads a research group and is currently co-director of the Edinburgh Cancer Discovery Unit and the Edinburgh Phenotypic Assay Centre. Primary research interests include advancing High-content analysis, phenotypic screening, Reverse Phase Protein Array technology, drug combinations and cancer drug discovery.

****************************
*** *** *** ****
 
For speaker's contact information - Contact us

Specialties

Clinical Pharmacology

Interested Topics

Clinical Pharmacology, Drug-Discovery; Pharmaco-proteomics, High-content Screening, Tumour Invasion & Metastasis, 3D/organotypic Assays, Protease-kinase Pathway Crosstalk, Drug Combinations, Phenotypic Screening

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message